127 related articles for article (PubMed ID: 30905320)
1. Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study.
Huang L; Balavarca Y; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Zadnik V; Primic-Žakelj M; Mägi M; Grützmann R; Besselink MG; Schrotz-King P; Brenner H; Jansen L
BMC Med; 2019 Mar; 17(1):66. PubMed ID: 30905320
[TBL] [Abstract][Full Text] [Related]
2. Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study.
Liu D; Quan H; Ma M; Zhou H; Yang X; Wu Z; Luo J; Xiao H; Xiao Y
BMC Cancer; 2024 Mar; 24(1):344. PubMed ID: 38500085
[TBL] [Abstract][Full Text] [Related]
3. The nomogram for the prediction of overall survival after surgery in patients in early-stage NSCLC based on SEER database and external validation cohort.
Zhang H; Zeng J; Li X; Zhang B; Wang H; Tang Q; Zhang Y; Bao S; Zu L; Xu X; Xu S; Song Z
Cancer Med; 2024 Jan; 13(1):e6751. PubMed ID: 38148585
[TBL] [Abstract][Full Text] [Related]
4. Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States.
Huang L; Jansen L; Balavarca Y; Verhoeven RHA; Ruurda JP; Van Eycken L; De Schutter H; Johansson J; Lindblad M; Johannesen TB; Zadnik V; Žagar T; Mägi M; Bastiaannet E; Lagarde SM; van de Velde CJH; Schrotz-King P; Brenner H
Clin Transl Med; 2020 Oct; 10(6):e203. PubMed ID: 33135354
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival and prognostic indicators in small (Pongprasobchai S; Pannala R; Smyrk TC; Bamlet W; Pitchumoni S; Ougolkov A; de Andrade M; Petersen GM; Chari ST
Pancreatology; 2008; 8(6):587-92. PubMed ID: 18849640
[TBL] [Abstract][Full Text] [Related]
6. Prediction of tumor recurrence after surgical resection of ampullary adenocarcinoma using magnetic resonance imaging.
Lee S; Lee JE; Kim KD; Hwang JA; Choi SY; Moon JE; Kim MJ
Eur Radiol; 2024 Mar; ():. PubMed ID: 38536460
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Nomogram to Predict the Benefit of Adjuvant Radiotherapy for Patients with Resected Gastric Cancer.
Yuan SQ; Wu WJ; Qiu MZ; Wang ZX; Yang LP; Jin Y; Yun JP; Gao YH; Li YH; Zhou ZW; Wang F; Xu RH
J Cancer; 2017; 8(17):3498-3505. PubMed ID: 29151934
[No Abstract] [Full Text] [Related]
8. Postoperative prognostic nomogram for adult grade II/III astrocytoma in the Chinese Han population.
Wang L; Zhang J; Wang J; Xue H; Deng L; Che F; Heng X; Zheng X; Lu Z; Yang L; Tan Q; Xu Y; Zhang Y; Ji X; Li G; Yang F; Xue F
Health Inf Sci Syst; 2023 Dec; 11(1):23. PubMed ID: 37151917
[TBL] [Abstract][Full Text] [Related]
9. Survival benefit of adjuvant chemotherapy in patients with resected gallbladder adenocarcinoma: An updated retrospective cohort analysis.
Wang Y; Kong Y; Yang Q; Zhong C; Zhou D; Wang W
Eur J Surg Oncol; 2024 Apr; 50(4):108047. PubMed ID: 38401352
[TBL] [Abstract][Full Text] [Related]
10. Predicting surgical benefit of primary tumor resection in patients with stage IV colorectal cancer.
Yang Y; Lam W; Lyu Z; Ouyang K; Chen R; Wang J; Wu D; Yang Z; Li Y
Asian J Surg; 2024 Apr; ():. PubMed ID: 38609833
[TBL] [Abstract][Full Text] [Related]
11. β6-Integrin Serves as a Potential Serum Marker for Diagnosis and Prognosis of Pancreatic Adenocarcinoma.
Lenggenhager D; Bengs S; Fritsch R; Hussung S; Busenhart P; Endhardt K; Töpfer A; The FO; Bütikofer S; Gubler C; Scharl M; Morell B
Clin Transl Gastroenterol; 2021 Aug; 12(8):e00395. PubMed ID: 34388137
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Effect of Preoperative Inflammatory Markers on Morbidity and Overall Survival in Pancreatic Adenocarsinoma.
Çaparlar MA; Durhan A; Süleymanov M; Binarbaşı C; Koşmaz K
Niger J Clin Pract; 2023 Dec; 26(12):1902-1909. PubMed ID: 38158359
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Survivors of Pancreatic Cancer: A California Population-Based Study.
Kardosh A; Lichtensztajn DY; Gubens MA; Kunz PL; Fisher GA; Clarke CA
Pancreas; 2018 Sep; 47(8):958-966. PubMed ID: 30074526
[TBL] [Abstract][Full Text] [Related]
14. Disparities in primary pancreatic adenocarcinoma survival by Medicaid-status: A national population-based risk analysis.
Ganga A; Kim EJ; Mintzer GL; Adriance W; Wang R; Cholankeril G; Balkrishnan R; Somasundar PS
Eur J Surg Oncol; 2023 Jul; 49(7):1242-1249. PubMed ID: 36801151
[TBL] [Abstract][Full Text] [Related]
15. Proposal of predictive model on survival in unresectable pancreatic cancer receiving systemic chemotherapy.
Ishii N; Nishikawa H; Iwata Y; Enomoto H; Tanaka H; Katakami N; Nishimura T; Iijima H; Nishiguchi S
J Cancer; 2020; 11(5):1223-1230. PubMed ID: 31956368
[No Abstract] [Full Text] [Related]
16. Prediction of survival in patients with infected pancreatic necrosis: a prospective cohort study.
Ning C; Ouyang H; Shen D; Sun Z; Liu B; Hong X; Lin C; Li J; Chen L; Li X; Huang G
Int J Surg; 2024 Feb; 110(2):777-787. PubMed ID: 37851523
[TBL] [Abstract][Full Text] [Related]
17. Opioid burden in patients with inoperable pancreatic adenocarcinoma and the development of a multivariable risk prediction model for opioid use: A retrospective cohort study.
Koulouris A; Baio G; Clark A; Alexandre L
Pancreatology; 2023 Nov; 23(7):818-828. PubMed ID: 37741797
[TBL] [Abstract][Full Text] [Related]
18. Development and Application of a Novel Machine Learning Model Predicting Pancreatic Cancer-Specific Mortality.
Sun Y; Hu S; Li X; Wu Y
Cureus; 2024 Mar; 16(3):e57161. PubMed ID: 38681451
[TBL] [Abstract][Full Text] [Related]
19. Epigenomic Blood-Based Early Detection of Pancreatic Cancer Employing Cell-Free DNA.
Haan D; Bergamaschi A; Friedl V; Guler GD; Ning Y; Reggiardo R; Kesling M; Collins M; Gibb B; Hazen K; Bates S; Antoine M; Fraire C; Lopez V; Malta R; Nabiyouni M; Nguyen A; Phillips T; Riviere M; Leighton A; Ellison C; McCarthy E; Scott A; Gigliotti L; Nilson E; Sheard J; Peters M; Bethel K; Chowdhury S; Volkmuth W; Levy S
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1802-1809.e6. PubMed ID: 36967102
[TBL] [Abstract][Full Text] [Related]
20. The impact of a history of cancer on pancreatic ductal adenocarcinoma survival.
He X; Li Y; Su T; Lai S; Wu W; Chen L; Si J; Sun L
United European Gastroenterol J; 2018 Jul; 6(6):888-894. PubMed ID: 30023066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
